Category: Uncategorized
Events

HSE Grand Rounds to Feature Laura James

Laura James, MD, director of the Translational Research Institute and vice chancellor for Clinical and Translational Research at UAMS, will be the featured speaker at 2 p.m. Wednesday, April 9, for the Health Sciences Entrepreneurship Grand Rounds.  James, who is co-founder of the rapid acetaminophen-induced liver injury testing company Acetaminophen Toxicity Diagnostics, will speak about “Creating a New Diagnostic Test: Translational Science Principles in Action.”  Join us at the Winthrop P. Rockefeller Cancer Institute, 10th Floor, Betsy Blass Conference Room, Room 10014.  The UAMS community and public are welcome to attend.  HSE Grand Rounds are sponsored by the Translational Research Institute’s Health Sciences Innovation and Entrepreneurship Postdoctoral Training Program and BioVentures LLC. 

Read More »
April 3, 2025
Education

From Idea to Impact: How IP Powers Public Good

Join us at 2 p.m. Wednesday, Oct. 16, for Health Sciences Entrepreneurship Grand Rounds, featuring Eric Peterson, Ph.D., BioVentures LLC interim president, at the Winthrop P. Rockefeller Cancer Institute, Betsy Blass Conference Room, 10th Floor. In this session, “From Idea to Impact: How IP Powers Public Good,” Peterson will explore the pivotal role of intellectual property in driving public benefit.

Read More »
October 15, 2024
News

Submit Your Idea: ARHVA Awardees Receive Support Toward Commercialization

The AR Health Ventures Accelerator (ARHVA) invites UAMS employees to submit innovative therapeutic or drug discovery ideas for significant financial and administrative support toward commercialization.  Selected projects receive financial grants of up to $50,000, project management, budget allocation and progress tracking. This unique support framework allows researchers to focus on their innovations, while ARHVA ensures projects stay on track, increasing the commercial value and paving the way for successful licensing, partnerships or startups.  All UAMS employees are eligible to apply, including trainees and postdoctoral fellows. The full Request for Applications document outlining the application process is available on the ARHVA website, as is a detailed FAQ. The application period begins August 26, 2024, and runs through September 30, 2024, at 5 PM. The funding decision announcement will be November 29, 2024​. Read about inaugural ARHVA cohort, who are tackling biofilm formation in Staphylococcus aureus infections, radiation-responsive liposomes for cancer therapy, and a novel biomarker for liver injury detection.  For more information, contact BioVentures Senior Program Manager Stefanie Kennon-McGill, Ph.D., at skennonmcgill@uams.edu.

Read More »
August 26, 2024